Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism

Summary

Allogeneic (not from the subject) human umbilical cord tissue-derived stem cells administered intravenously (IV) in a series of 4 infusions every 3 months over the course of one year is safe and will induce a therapeutic effect in autism patients.

Timeline

Start

2014-07

Primary completion

2017-08

Completion

2017-08

Drugs

Indications